NORTHWESTERN MEDICINE EXPERTS AT TRANSCATHETER CARDIOVASCULAR THERAPEUTICS (TCT) 2024
Transcatheter Cardiovascular Therapeutics (TCT) 2024, organized by the Cardiovascular Research Foundation (CRF), will be held from October 27 through 30 at the Walter E. Washington Convention Center in Washington, D.C.
TCT is an annual scientific symposium and the world’s foremost educational forum specializing in interventional cardiovascular medicine. For more than three decades, TCT has ignited innovation, education and connection in interventional cardiology, with the purpose of improving the survival and quality of life of patients suffering from heart and vascular disease. This four-day comprehensive, practical and interactive experience is led by experts in coronary, structural and endovascular interventions.
TCT is an annual scientific symposium and the world’s foremost educational forum specializing in interventional cardiovascular medicine. For more than three decades, TCT has ignited innovation, education and connection in interventional cardiology, with the purpose of improving the survival and quality of life of patients suffering from heart and vascular disease. This four-day comprehensive, practical and interactive experience is led by experts in coronary, structural and endovascular interventions.
NORTHWESTERN MEDICINE PRESENTATION HIGHLIGHTS
Date
|
Time
|
Location
|
Session
|
Presenter
|
Monday, October 28
|
2:00 – 3:00 pm EDT
|
Structural Spotlight Room, Education & Training Hall (Halls D-E), Level 2, Walter E. Washington Convention Center
|
The BEST of THT 2024
|
3:40 – 4:40 pm EDT
|
Structural Theater, Education & Training Hall (Halls D-E), Level 2, Walter E. Washington Convention Center
|
The "Modern Era" of Aortic Regurgitation: Diagnosis and Therapy
|
4:50 – 5:50 pm EDT
|
Structural Spotlight Room, Education & Training Hall (Halls D-E), Level 2, Walter E. Washington Convention Center
|
(Moderator) Structural Spotlight 6: Technologies, Patient Responders, and Future Directions
|
Tuesday, October 29
|
7:30 – 8:30 am EDT
|
Structural Spotlight Room, Education & Training Hall (Halls D-E), Level 2, Walter E. Washington Convention Center
|
Tricuspid Regurgitation: Fundamentals and Updates – ‘What to Remember About the Once Forgotten Valve’
|
7:30 – 9:00 am EDT
|
FDA Theater, Innovation & Exhibit Hall (Halls A-C), Lower Level, Walter E. Washington Convention Center
|
FDA Townhall 3: Diversity, Equity, and Inclusion: Not Just a Slogan Anymore!
|
8:40 – 9:40 am EDT
|
Main Arena, Ballroom, Level 3, Walter E. Washington Convention Center
|
Keeping Patients out of DanGer: Improving Clinical Outcome in Cardiogenic Shock
|
8:40 – 9:40 am EDT
|
Structural Spotlight Room, Education & Training Hall (Halls D-E), Level 2, Walter E. Washington Convention Center
|
(Moderator) Structural Spotlight 8: Deep Dive: Transcatheter Tricuspid TEER
|
9:50 – 10:50 am EDT
|
Innovation Theater, Innovation & Exhibit Hall (Halls A-C), Lower Level, Walter E. Washington Convention Center
|
TCT Innovation 9: Innovations in Mechanical Circulatory Support Devices
|
10:30 – 11:45 am EDT
|
Presentation Theater 4, Innovation & Exhibit Hall (Halls A-C), Lower Level, Walter E. Washington Convention Center
|
(Satellite Presenter) Current Limitations and Future Directions for Coronary Revascularization Trials: the RECHARGE Trials Program
|
11:00 – 12:30 pm EDT
|
Innovation Theater, Innovation & Exhibit Hall (Halls A-C), Lower Level, Walter E. Washington Convention Center
|
TCT Innovation 10: Innovations in Transcatheter Mitral Valve Replacement Technologies
|
11:00 – 12:30 pm EDT
|
Coronary Theater, Education & Training Hall (Halls D-E), Level 2, Walter E. Washington Convention Center
|
Coronary Theater 9: Live Case 6 and Multivessel PCI With Severe LV Dysfunction and Mechanical Circulatory Support
|
2:00 – 2:45 pm EDT
|
Structural Theater, Education & Training Hall (Halls D-E), Level 2, Walter E. Washington Convention Center
|
Structural Theater 10A: Case-Based Transcatheter Tricuspid Device Selection: Clinical Focus and Anatomic Considerations
|
2:00 – 2:58 pm EDT
|
Moderated Abstracts Station 6, Innovation & Exhibit Hall (Halls A-C), Lower Level, Walter E. Washington Convention Center
|
TAVR and Arrhythmias and Conduction Disturbances – 2
|
2:45 – 3:30 pm EDT
|
Structural Theater, Education & Training Hall (Halls D-E), Level 2, Walter E. Washington Convention Center
|
Structural Theater 10B: Case-Based Management of Complex TR Scenarios: Insights From the Heart Team
|
3:40 – 4:40 pm EDT
|
Innovation Theater, Innovation & Exhibit Hall (Halls A-C), Lower Level, Walter E. Washington Convention Center
|
TCT Innovation 12: Innovations in Transcatheter Tricuspid Valve Repair Technologies
|
3:40 – 4:40 pm EDT
|
Structural Spotlight Room, Education & Training Hall (Halls D-E), Level 2, Walter E. Washington Convention Center
|
Structural Spotlight 11: Disease-Based Management of Secondary MR
|
3:40 – 4:40 pm EDT
|
Structural Theater, Education & Training Hall (Halls D-E), Level 2, Walter E. Washington Convention Center
|
Tricuspid Valve Interventions: Complications and Controversies
|
4:00 – 5:10 pm EDT
|
Moderated Abstracts Station 4, Innovation & Exhibit Hall (Halls A-C), Lower Level, Walter E. Washington Convention Center
|
TAVR and Co-morbidities
|
4:50 – 5:50 pm EDT
|
Structural Theater, Education & Training Hall (Halls D-E), Level 2, Walter E. Washington Convention Center
|
(Moderator) Structural Theater 12: Live Case 7: Tricuspid TEER – University of Washington Medical Center
|
4:50 – 5:50 pm EDT
|
Main Arena, Ballroom, Level 3, Walter E. Washington Convention Center
|
Renal Denervation for Hypertension: What Comes Next?
|
Wednesday, October 30
|
7:30 – 8:30 am EDT
|
Structural Spotlight Room, Education & Training Hall (Halls D-E), Level 2, Walter E. Washington Convention Center
|
(Moderator) Structural Spotlight 13: "Pre-emptive" Treatment of Aortic Stenosis: An Emerging Strategy
|
7:30 – 9:00 am EDT
|
FDA Theater, Innovation & Exhibit Hall (Halls A-C), Lower Level, Walter E. Washington Convention Center
|
FDA Townhall Session 5A: Transcatheter Tricuspid Valve Intervention (TTVI): Trial Design Considerations Post TRILUMINATE and TRISCEND II
|
8:40 – 9:40 am EDT
|
Innovation Theater, Innovation & Exhibit Hall (Halls A-C), Lower Level, Walter E. Washington Convention Center
|
TCT Innovation 15: Current and Future Impact of AI on Cardiovascular Medicine
|
11:00 – 12:30 pm EDT
|
Structural Theater, Education & Training Hall (Halls D-E), Level 2, Walter E. Washington Convention Center
|
Structural Theater 16: Live Case 9 – TTVR and Tricuspid Valve Interventions: From Clinical Trials to Clinical Practice
|
11:00 – 12:30 pm EDT
|
Structural Theater, Education & Training Hall (Halls D-E), Level 2, Walter E. Washington Convention Center
|
Tricuspid Valve Interventions: From Clinical Trials to Clinical Practice
|
11:00 – 12:31 pm EDT
|
Main Arena, Ballroom, Level 3, Walter E. Washington Convention Center
|
(Moderator) Late-Breaking Clinical Trials: Session III, in Collaboration with the Journal of the American Medical Association
|
12:30 – 1:30 pm EDT
|
Presentation Theater 3, Innovation & Exhibit Hall (Halls A-C), Lower Level, Walter E. Washington Convention Center
|
(Moderator) The Rise of AHA Target: Aortic Stenosis – Applying Quality Improvement Upstream of the Procedure (in partnership with the American Heart Association)
|
follow northwestern medicine Cardiovascular
|
|
|